Galenica Santé acquires the brands Merfen and Vita-Merfen

22. February 2017

Galenica Santé acquires the brands Merfen and Vita-Merfen.

Vifor Consumer Health Ltd., a subsidiary of the santé business of Galenica Ltd. has signed an asset purchase agreement with Glaxo Smith Kline to acquire the wound careproducts Merfen and Vita-Merfen and all related intellectual property rights and the market authorizations in several jurisdictions. The M&A Team of Kellerhals Carrard (Brechbühl (Lead)/Matter (Co-Lead))  advised the Galenica/Vifor Consumer Health in the drafting and negotiating of the transaction.

 

(https://www.nzz.ch/wirtschaft/gesundheitsgruppe-galenica-steigt-mit-merfen-in-wundversorgungs-markt-ein-ld.147023)